Expression of early growth response-1 in colorectal cancer and its relation to tumor cell proliferation and apoptosis

Oncology Reports

Volumn 31, Issue 2, 2014, Pages 788-794

  Myung, Dae Seong ^a   Park, Young Lan ^a   Kim, Nuri ^a   Chung, Cho Yun ^a   Park, Hyung Chul ^a   Kim, Jong Sun ^a   Cho, Sung Bum ^a   Lee, Wan Sik ^a   Lee, Jae Hyuk ^a   Joo, Young Eun ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Apoptosis; Cell proliferation; Colorectal neoplasm; Early growth response 1

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; KI 67 ANTIGEN; MESSENGER RNA;

ADULT; AGE; AGED; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL FEATURE; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; EARLY GROWTH RESPONSE PROTEIN 1; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; SURVIVAL; TUMOR CELLS, CULTURED;

EID: 84892386298     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2884     Document Type: Article

References (38)

1. Raff MC: Social controls on cell survival and cell death. Nature 356: 397-400, 1992.
2. DeBerardinis RJ, Lum JJ, Hatzivassiliou G and Thompson CB: The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7: 11- 20, 2008.
3. Schultz DR and Harrington WJ Jr: Apoptosis: programmed cell death at a molecular level. Semin Arthritis Rheum 32: 345-369, 2003.
4. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462, 1995.
5. Kiechle FL and Zhang X: Apoptosis: biochemical aspects and clinical implications. Clin Chim Acta 326: 27-45, 2002.
6. Milbrandt J: A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science 238: 797-799, 1987.
7. Gashler A and Sukhatme VP: Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog Nucleic Acid Res Mol Biol 50: 191-224, 1995.
8. Fahmy RG and Khachigian LM: Antisense Egr-1 RNA driven by the CMV promoter is an inhibitor of vascular smooth muscle cell proliferation and regrowth after injury. J Cell Biochem 84: 575-582, 2002.
9. Rupprecht HD, Hoffer G, de Heer E, Sterzel RB, Faller G and Schoecklmann HO: Expression of the transcriptional regulator Egr-1 in experimental glomerulonephritis: requirement for mesangial cell proliferation. Kidney Int 51: 694-702, 1997.
10. Yan SF, Fujita T, Lu J, et al: Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med 6: 1355-1361, 2000.
11. O'Donovan KJ, Tourtellotte WG, Millbrandt J and Baraban JM: The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience. Trends Neurosci 22: 167-173, 1999.
12. Lemaire P, Revelant O, Bravo R and Charnay P: Two mouse genes encoding potential transcription factors with identical DNA-binding domains are activated by growth factors in cultured cells. Proc Natl Acad Sci USA 85: 4691-4695, 1988.
13. Liu C, Yao J, de Belle I, Huang RP, Adamson E and Mercola D: The transcription factor EGR-1 suppresses transformation of human fibrosarcoma HT1080 cells by coordinated induction of transforming growth factor- β1, fibronectin, and plasminogen activator inhibitor-1. J Biol Chem 274: 4400-4411, 1999.
14. Liu C, Yao J, Mercola D and Adamson E: The transcription factor EGR-1 directly transactivates the fibronectin gene and enhances attachment of human glioblastoma cell line U251. J Biol Chem 275: 20315-20323, 2000.
15. Shareef MM, Cui N, Burikhanov R, et al: Role of tumor necrosis factor- α and TRAIL in high-dose radiation-induced bystander signaling in lung adenocarcinoma. Cancer Res 67: 11811-11820, 2007.
16. Huang RP, Fan Y, de Belle I, et al: Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int J Cancer 72: 102-109, 1997.
17. Gitenay D and Baron VT: Is EGR1 a potential target for prostate cancer therapy? Future Oncol 5: 993-1003, 2009.
18. Riggs PK, Rho O and DiGiovanni J: Alteration of Egr-1 mRNA during multistage carcinogenesis in mouse skin. Mol Carcinog 27: 247-251, 2000.
19. Scharnhorst V, Menke AL, Attema J, et al: EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity. Oncogene 19: 791-800, 2000.
20. Eid MA, Kumar MV, Iczkowski KA, Bostwick DG and Tindall DJ: Expression of early growth response genes in human prostate cancer. Cancer Res 58: 2461-2468, 1998.
21. Arimochi H, Morita K, Kataoka K, Nakanishi S, Kuwahara T and Ohnishi Y: Suppressive effect of Clostridium perfringens -produced heat-stable substance(s) on proliferation of human colon adenocarcinoma HT29 cells in culture. Cancer Lett 241: 228-234, 2006.
22. Chen A, Xu J and Johnson AC: Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene 25: 278-287, 2006.
23. Mahalingam D, Natoni A, Keane M, Samali A and Szegezdi E: Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells. Br J Cancer 102: 754-764, 2010.
24. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds): AJCC Cancer Staging Manual. 7th edition. Springer, New York, pp143-163, 2010.
25. Gavrieli Y, Sherman Y and Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501, 1992.
26. Kobayashi D, Yamada M, Kamagata C, et al: Overexpression of early growth response-1 as a metastasis-regulatory factor in gastric cancer. Anticancer Res 22: 3963-3970, 2002.
27. Zheng L, Pu J, Jiang G, et al: Abnormal expression of early growth response 1 in gastric cancer: association with tumor invasion, metastasis and heparanase transcription. Pathol Int 60: 268-277, 2010.
28. McCormick D, Chong H, Hobbs C, Datta C and Hall PA: Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. Histopathology 22: 355-360, 1993.
29. Weidner N, Moore DH II and Vartanian R: Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel ?paraffin'-reactive MIB1 antibody. Hum Pathol 25: 337-342, 1994.
30. Oka S, Uramoto H, Shimokawa H, Iwanami T and Tanaka F: The expression of Ki-67, but not proliferating cell nuclear antigen, predicts poor disease free survival in patients with adenocarcinoma of the lung. Anticancer Res 31: 4277-4282, 2011.
31. He WL, Li YH, Yang DJ, et al: Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma. Eur J Surg Oncol 39: 141-149, 2013.
32. Hilska M, Collan YU, O Laine VJ, et al: The significance of tumor markers for proliferation and apoptosis in predicting survival in colorectal cancer. Dis Colon Rectum 48: 2197-2208, 2005.
33. Sun T, Tian H, Feng YG, Zhu YQ and Zhang WQ: Egr-1 promotes cell proliferation and invasion by increasing β-catenin expression in gastric cancer. Dig Dis Sci 58: 423-430, 2013.
34. Kyrylkova K, Kyryachenko S, Leid M and Kioussi C: Detection of apoptosis by TUNEL assay. Methods Mol Biol 887: 41-47, 2012.
35. Lifshitz S, Lamprecht SA, Benharroch D, Prinsloo I, Polak-Charcon S and Schwartz B: Apoptosis (programmed cell death) in colonic cells: from normal to transformed stage. Cancer Lett 163: 229-238, 2001.
36. Sezer C, Yildirim M, Yildiz M, et al: Prognostic significance of biological apoptosis factors in gastric cancer. J BUON 18: 138-146, 2013.
37. Hernandez JM, Farma JM, Coppola D, et al: Expression of the antiapoptotic protein survivin in colon cancer. Clin Colorectal Cancer 10: 188-193, 2011.
38. Theodoropoulos GE, Gazouli M, Vaiopoulou A, et al : Polymorphisms of caspase 8 and caspase 9 gene and colorectal cancer susceptibility and prognosis. Int J Colorectal Dis 26: 1113-1118, 2011